Lv3
270 积分 2025-12-26 加入
CDK4/6 inhibition provides additional efficacy in HER2+, HR+ breast cancer
9天前
已完结
Gorham-Stout综合征的多学科诊疗一例
19天前
已完结
贝伐珠单抗联合仑伐替尼治疗原发性肝癌TACE术后患者对血清肿瘤标志物及CD4+/CD8+水平的影响
19天前
已完结
帕妥珠联合化疗治疗HER2阳性乳腺癌的临床评价
1个月前
已完结
Breaking resistance barriers: ensartinib as a milestone in anaplastic lymphoma kinase–driven non-small cell lung cancer therapy
1个月前
已完结
1081eP EGFR exon 19 duplications/insertions, rare but potential therapeutic targets for NSCLC: A real-world study and pooled analysis of case series
1个月前
已关闭
Clinical efficacy and safety of Cadonilimab immunotherapy in recurrent or metastatic gynecological malignancies: a retrospective study
1个月前
已完结
1例EGFR突变合并PD-L1表达非鳞状NSCLC患者的病例分析
2个月前
已完结
合并恶性腹腔积液的晚期肝癌长程管理实践1例
2个月前
已完结
皖公网安备34019202002308
